Dexcom Inc (NASDAQ: DXCM) is 8.12% higher on its value in year-to-date trading and has touched a low of $74.75 and a high of $139.55 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DXCM stock was last observed hovering at around $134.72 in the last trading session, with the day’s loss setting it -0.55%.
Currently trading at $134.17, the stock is 7.70% and 8.01% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.27 million and changing -0.41% at the moment leaves the stock 17.93% off its SMA200. DXCM registered 17.77% gain for a year compared to 6-month gain of 40.79%. The firm has a 50-day simple moving average (SMA 50) of $14.24 and a 200-day simple moving average (SMA200) of $56.28.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 14.63% loss in the last 1 month and extending the period to 3 months gives it a 9.45%, and is -0.89% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.09% over the week and 3.19% over the month.
Dexcom Inc (DXCM) has around 9600 employees, a market worth around $51.72B and $3.62B in sales. Current P/E ratio is 102.37 and Fwd P/E is 60.32. Profit margin for the company is 14.95%. Distance from 52-week low is 79.49% and -3.86% from its 52-week high. The company has generated returns on investments over the last 12 months (11.67%).
Dexcom Inc quarterly earnings per share for the current quarter are estimated at $0.27 with sales reaching $910.03M over the same period.The EPS is expected to grow by 15.08% this year, but quarterly earnings will post 19.40% year-over-year. Quarterly sales are estimated to grow 26.30% in year-over-year returns.
Dexcom Inc (DXCM) Top Institutional Holders
1,427 institutions hold shares in Dexcom Inc (DXCM), with institutional investors hold 103.40% of the company’s shares. The shares outstanding are 385.40M, and float is at 377.36M with Short Float at 4.41%. Institutions hold 102.96% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 44.28 million shares valued at $5.69 billion. The investor’s holdings represent 11.42% of the DXCM Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 33.25 million shares valued at $4.27 billion to account for 8.57% of the shares outstanding. The other top investors are Baillie Gifford and Company which holds 16.72 million shares representing 4.31% and valued at over $2.15 billion, while State Street Corporation holds 4.27% of the shares totaling 16.54 million with a market value of $2.13 billion.
Dexcom Inc (DXCM) Insider Activity
The most recent transaction is an insider sale by Dolan Matthew Vincent,the company’sEVP Strategy & Corp Dev. SEC filings show that Dolan Matthew Vincent sold 4,203 shares of the company’s common stock on Mar 15 ’24 at a price of $130.21 per share for a total of $0.55 million. Following the sale, the insider now owns 44367.0 shares.
Dexcom Inc disclosed in a document filed with the SEC on Mar 12 ’24 that SAYER KEVIN R (President CEO and Chairman) sold a total of 81,007 shares of the company’s common stock. The trade occurred on Mar 12 ’24 and was made at $133.36 per share for $10.8 million. Following the transaction, the insider now directly holds 0.33 million shares of the DXCM stock.
Still, SEC filings show that on Mar 12 ’24, Stern Sadie (EVP Chief Human Resources) disposed off 20,321 shares at an average price of $133.61 for $2.72 million. The insider now directly holds 80,441 shares of Dexcom Inc (DXCM).
